Kynam Capital Management, LP Akouos, Inc. Transaction History

Kynam Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$2.6 - $5.16 $869,986 - $1.73 Million	334,610 Added 87.19%	718,394 $4.86 Million
Q2 2022 Aug 15, 2022	SELL	$2.46 - $5.2 $10,105 - $21,361	-4,108 Reduced 1.06%	383,784 $1.8 Million
Q1 2022 May 13, 2022	BUY	$4.16 - $9.08 $1.2 Million - $2.62 Million	288,884 Added 291.78%	387,892 $1.84 Million
Q4 2021 Feb 14, 2022	BUY	$7.65 - $11.38 $757,411 - $1.13 Million	99,008 New	99,008 $842,000

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Kynam Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Kynam Capital Management, LP with notifications on news.